Krystal Biotech, Inc. - Common Stock (NQ:KRYS)
364.23
+12.41
(+3.53%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 28, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 420,223 |
| Open | 355.76 |
| Bid (Size) | 347.00 (40) |
| Ask (Size) | 378.60 (40) |
| Prev. Close | 351.82 |
| Today's Range | 350.10 - 364.95 |
| 52wk Range | 130.50 - 382.54 |
| Shares Outstanding | 22,205,642 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
3 Soaring Stocks That May Have More Upside Ahead ↗
July 07, 2026
Krystal (KRYS) Q1 2026 Earnings Transcript ↗
May 04, 2026
Krystal (KRYS) Q1 2025 Earnings Transcript ↗
May 04, 2026
Is Vertex Pharmaceuticals' Empire in Trouble? ↗
April 16, 2026
Frequently Asked Questions
Is Krystal Biotech, Inc. - Common Stock publicly traded?
Yes, Krystal Biotech, Inc. - Common Stock is publicly traded.
What exchange does Krystal Biotech, Inc. - Common Stock trade on?
Krystal Biotech, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Krystal Biotech, Inc. - Common Stock?
The ticker symbol for Krystal Biotech, Inc. - Common Stock is KRYS on the Nasdaq Stock Market
What is the current price of Krystal Biotech, Inc. - Common Stock?
The current price of Krystal Biotech, Inc. - Common Stock is 364.23
When was Krystal Biotech, Inc. - Common Stock last traded?
The last trade of Krystal Biotech, Inc. - Common Stock was at 07/28/26 04:00 PM ET
What is the market capitalization of Krystal Biotech, Inc. - Common Stock?
The market capitalization of Krystal Biotech, Inc. - Common Stock is 8.09B
How many shares of Krystal Biotech, Inc. - Common Stock are outstanding?
Krystal Biotech, Inc. - Common Stock has 8B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
Facebook
Twitter
YouTube